Navigation Links
New Data Shows Ongoing Benefits of Percutaneous MitraClip(R) Device for Patients With Mitral Regurgitation
Date:10/24/2007

uccessful MitraClip procedure, significant reverse

remodeling of the left ventricle was demonstrated. Reverse remodeling

was assessed based on five echocardiographic measures, including left

ventricular end-systolic dimension.

-- In line with the reverse remodeling, 94 percent of patients who had a

successful result with the MitraClip device had improved or stable New

York Heart Association (NYHA) Class at 12 months following the

procedure.

"Our work to reduce mitral regurgitation with a percutaneous approach continues to produce compelling results," said Ted Feldman, M.D., who presented the 36 month follow-up data at TCT. Dr. Feldman is the EVEREST II national co-principal investigator and director of the cardiac catheterization lab at Evanston Northwestern Healthcare in Evanston, Illinois. "The reduction in MR severity achieved, along with the stability of the results at 36 months and the preservation of subsequent surgical options, leads us to believe that the MitraClip device is likely to become a viable first-line option for treating MR in many patients."

Dr. Michael Rinaldi, who presented the reverse remodeling data at TCT, concurred. "The reverse remodeling data is important in that it provides compelling, objective evidence that the MitraClip device is having a positive impact on patients," said Dr. Rinaldi, director of clinical research at Sanger Clinic/Carolinas Medical Center. "Additionally, patients with the MitraClip report that they feel better and are able to engage more fully in activities they enjoy."

EVEREST Study Continues Enrollment

The EVEREST study continues at more than 35 centers in North America, with more than 300 patients enrolled and more than 300 MitraClip devices implanted to date. Investigators are currently enrolling patients in both arms of the EVEREST II study -- a randomized, controlled arm and a high risk registry arm -- with the goal of completing
'/>"/>

SOURCE Evalve, Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Study Shows Regenecare Relieves Pain and Itching of Skin Rashes Caused by Widely Used Cancer Drugs
2. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
3. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
4. MediGene Announces Cancer-Fighting Virus Shows Promise in Early Clinical Trial
5. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
6. Ceragenix Compound Shows Promise for Treating Lethal Cystic Fibrosis Infections
7. Largest Cervical Cancer Vaccine Efficacy Trial Shows Cervarix Provides Excellent Protection Against Lesions Caused by Most Common Cancer-Causing Virus Types
8. CombinatoRx Product Candidate CRx-150 Shows Activity on DAS28 and Pain, but Not CRP
9. New Study Shows A1c Reduced Safely By Patients With Type 2 Diabetes Using Self-Adjusted Dosing Starting With Once-Daily Insulin Treatment Levemir
10. First Phase II Short-Term Study on Dapagliflozin Shows Results on Safety, Tolerability and Glycemic Markers in Subjects With Type 2 Diabetes
11. New Poll Shows Men, Women Incorrectly Blame Symptoms of Low Testosterone on Normal Aging
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... Dec. 14 In response to an ... 2009, in which the Agency recommended that healthcare ... (SS1) sterile processing system, hospitals throughout the U.S. ... alternatives to that product. According to the FDA, ... SS1 that may affect the safety or the ...
(Date:12/14/2009)... 14 Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA ... Drug Application (NDA) for Staccato® loxapine (AZ-004) to the ... an inhalation product candidate being developed for the rapid ... disorder. The IND for Staccato loxapine ... "AZ-004 has delivered a predictable and consistent safety and ...
(Date:12/14/2009)... -- Cardinal Health today announced that executives of the ... Goldman Sachs CEO Unplugged Conference on ... Conference Center in New York. 28th Annual ... Noon EST at the Westin St. Francis Hotel in ... will discuss Cardinal Health,s diverse products and services, company ...
Breaking Medicine Technology:ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 2ECRI Institute Issues Steris System 1 High Priority Alert and Recommendations: Free Guidance to Help Hospitals Map out Transition to Alternative Reprocessing Methods 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 2Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 3Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 4Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 5Alexza Announces Submission of AZ-004 (Staccato(R) Loxapine) NDA 6Cardinal Health Executives to Speak at Two Investor Events in January 2New National Nurse Talk Radio Show Takes Off with Humor Health and a Voice for the Patient Advocate 61727 1New National Nurse Talk Radio Show Takes Off with Humor Health and a Voice for the Patient Advocate 61727 2New National Nurse Talk Radio Show Takes Off with Humor Health and a Voice for the Patient Advocate 61727 3Duplicate File Detective v3 0 Provides Enterprise Grade Duplicate File Management 61725 1Duplicate File Detective v3 0 Provides Enterprise Grade Duplicate File Management 61725 2Spray May Delay Ejaculation 61723 1Spray May Delay Ejaculation 61723 2
... WEST CHESTER, Ohio, Jan. 7 AtriCure, Inc.,(Nasdaq: ... a leader in cardiac surgical,ablation products, today announced ... products, which physicians have adopted to,treat atrial fibrillation ... by Dr. James H. Wudel, a prominent cardiac ...
... Fovea Pharmaceuticals SA, which, last,December 2007, raised ... announced that,its product, Recombinant human rod-derived cone ... Medicinal Product from the,European Commission, following the ... Evaluation of Medicinal Products (EMEA) Committee for ...
Other Medicine Technology:Positive Results Published Using AtriCure Minimally Invasive Products 2Positive Results Published Using AtriCure Minimally Invasive Products 3Positive Results Published Using AtriCure Minimally Invasive Products 4Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 2Fovea Pharmaceuticals Receives Orphan Drug Designation from EC for RdCVF for the Treatment of Retinitis Pigmentosa 3
(Date:12/14/2009)... But the bump in odds is small and shouldn,t ... (HealthDay News) -- Older women who take antidepressants may ... stroke and death compared to women not on the ... can be different from clinical significance," stressed Dr. Jordan ... Medical School, and lead author of a report in ...
(Date:12/14/2009)... team of scientists from the UC San Diego School ... a protein switch that helps prevent liver damage, including ... better understanding of how the protein, TAK1, works could ... disease and cancer. , "TAK1 appears to be ... Brenner, MD, professor of medicine and Dean of the ...
(Date:12/14/2009)... and highly stigmatized, according to psychiatrists Charles F. ... So these Washington University physicians have written a ... Psychiatry," Zorumski and Rubin, who have more than ... helping patient families, say some of the problems ... a lack of understanding psychiatry and what psychiatrists ...
(Date:12/14/2009)... Study links perceived age to physical, mental functioning , ... look younger than their age tend to live longer ... new study suggests. , The finding came from research ... who were given physical and cognitive tests and then ... at the photos and indicated the age they perceived ...
(Date:12/14/2009)... Lesions Quickly and Accurately for Biopsy , ... ... Dilon Diagnostics announced today that the U.S. Food and ... system for molecular imaging biopsy guidance. , , ,GammaLMc® ... 6800 Gamma Camera. The GammaLMc® (GL) system will help doctors ...
Breaking Medicine News(10 mins):Health News:Antidepressants May Raise Women's Stroke Risk 2Health News:Antidepressants May Raise Women's Stroke Risk 3Health News:Scientists uncover protective mechanism against liver cancer 2Health News:Book demystifies psychiatry for the general public 2Health News:Book demystifies psychiatry for the general public 3Health News:Looking Younger Than Your Age May Mean Longer Life 2Health News:Dilon Diagnostics Gamma-Guided Localization System Cleared by FDA 2
... IPC The Hospitalist Company, Inc. (Nasdaq: IPCM ), a leading national physician group practice company, ... be held on May 18th and 19th in Boston, MA. , ... and COO, Date: ... Time: ...
... 5 The following is a statement by Joon ... of Swine Flu Fear (SFF) in the United States ... over a menace that authorities around the world are ... SFF is highly contagious, and even a brief exposure ...
... UVC to fan coils, unit ventilators and indoor air ... for Air Handlers from Steril-Aire, Inc. may be used ... microorganisms including flu viruses, bacteria and mold. The ... coil units, unit ventilator systems and indoor air handlers ...
... can stimulate the appetite particularly among hospitalized seniors ... in The Gerontologist . , "The more social ... the better food intake will be," says Danielle St-Arnaud ... Department of Nutrition, St-Arnaud McKenzie conducted the study with ...
... U.S. Attorney A. Brian Albritton announces the ... Prosecution Agreement concerning WellCare Health Plans, Inc. (WellCare). ... executives and employees, in an elaborate scheme to ... Healthy Kids Corporation ("Healthy Kids" or FHKC) program ...
... Americans Month, the American Foundation for the Blind (AFB) has ... falls among seniors with vision loss. This year,s theme ... for a Better Tomorrow" -- reflects the ... throughout the country that are helping older adults have better ...
Other Medicine News:Health News:IPC The Hospitalist Company, Inc. to Present at Deutsche Bank's 34th Annual Health Care Conference 2Health News:Swine Flu Fear (SFF) Now a Pandemic 2Health News:New UVC Kit Destroys Microorganisms Including flu Viruses, Bacteria and Mold 2Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 2Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 3Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 4Health News:Charges Filed Against WellCare Health Plans, Inc.; WellCare Enters Into Deferred Prosecution Agreement, Agrees to Pay $80 Million in Restitution and Forfeiture 5Health News:Preventing Dangerous Slips and Falls: The American Foundation for the Blind Launches New Video Series on Staying Safe at Home 2
... The latest from the leader in automatic ... and modern approach to slide staining, ending ... peripheral blood smears, bone marrow and other ... the Aerospray stainer becomes a superb cytocentrifuge ...
HMS 760 Robot Stainer. Version includes display....
Cholesterol, Total. An automated analyzer test kits....
For the quantitative determination of total cholesterol in serum....
Medicine Products: